UNITED THERAPEUTICS Corp (UTHR) insider trading
Every open-market stock purchase and sale by UNITED THERAPEUTICS Corp executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- Martine A Rothblatt (CEO) and 2 others sold $325M in the last 90 days.
- Last company insider buy: Martine A Rothblatt (CEO), $864K, 5 months ago.
Last 12 months: insiders bought $864K (1 buy) and sold $1.4B (292 sales). Last close $598.72 on Oct 30, 2026.
Recent UTHR insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Oct 29, 2026 | Martine A Rothblatt (CEO) | Bought (not open market) | $1.1M |
| Oct 29, 2026 | Martine A Rothblatt (CEO) | Sold | $1M |
| Oct 29, 2026 | Martine A Rothblatt (CEO) | Sold | $927K |
| Oct 29, 2026 | Martine A Rothblatt (CEO) | Sold | $915K |
| Oct 29, 2026 | Martine A Rothblatt (CEO) | Sold | $809K |
| Oct 29, 2026 | Martine A Rothblatt (CEO) | Sold | $742K |
| Oct 29, 2026 | Martine A Rothblatt (CEO) | Sold | $653K |
| Oct 29, 2026 | Martine A Rothblatt (CEO) | Sold | $549K |
| Oct 29, 2026 | Martine A Rothblatt (CEO) | Sold | $31.3K |
| Oct 29, 2026 | Martine A Rothblatt (CEO) | Sold | $24K |
| Oct 29, 2026 | Martine A Rothblatt (CEO) | Bought (not open market) | — |
| Oct 28, 2026 | Martine A Rothblatt (CEO) | Sold | $1.8M |
| Oct 28, 2026 | Martine A Rothblatt (CEO) | Sold | $1.5M |
| Oct 28, 2026 | Martine A Rothblatt (CEO) | Bought (not open market) | $1.1M |
| Oct 28, 2026 | Martine A Rothblatt (CEO) | Sold | $1.1M |
| Oct 28, 2026 | Martine A Rothblatt (CEO) | Sold | $579K |
| Oct 28, 2026 | Martine A Rothblatt (CEO) | Sold | $479K |
| Oct 28, 2026 | Martine A Rothblatt (CEO) | Sold | $47.1K |
| Oct 28, 2026 | Martine A Rothblatt (CEO) | Bought (not open market) | — |
| Oct 27, 2026 | Martine A Rothblatt (CEO) | Bought (not open market) | $1.1M |
| Oct 27, 2026 | Martine A Rothblatt (CEO) | Sold | $941K |
| Oct 27, 2026 | Martine A Rothblatt (CEO) | Sold | $832K |
| Oct 27, 2026 | Martine A Rothblatt (CEO) | Sold | $829K |
| Oct 27, 2026 | Martine A Rothblatt (CEO) | Sold | $776K |
| Oct 27, 2026 | Martine A Rothblatt (CEO) | Sold | $592K |
Who's trading UTHR
- Martine A Rothblatt, CEO: bought $864K (1 buy), sold $923M (1963 sales), last Oct 29, 2026
- Paul A Mahon, VP: sold $108M (193 sales), last Oct 15, 2026
- Nilda Mesa, Insider: sold $356K (4 sales), last Sep 14, 2026
- Richard Giltner, Insider: other filings, last Jul 22, 2026
- Ray Kurzweil, Insider: sold $2.4M (1 sale), last Jul 22, 2026
- Kevin Tracey, Insider: other filings, last Jul 22, 2026
- Christopher Causey, Insider: sold $2.3M (5 sales), last Jul 22, 2026
- Victor J Dzau, Insider: other filings, last Jul 22, 2026
- Linda Maxwell, Insider: other filings, last Jul 22, 2026
- Judy D. Olian, Insider: sold $417K (4 sales), last Jul 22, 2026
- Christopher Patusky, Insider: sold $2.7M (3 sales), last Jul 22, 2026
- Louis W Sullivan, Insider: sold $3M (2 sales), last Jul 22, 2026
- Tommy G Thompson, Insider: sold $2.5M (5 sales), last Jul 22, 2026
- Jan Malcolm, Insider: sold $373K (9 sales), last Jul 22, 2026
- James Edgemond, CFO: sold $210M (370 sales), last Jun 22, 2026
Get free alerts when an insider at UNITED THERAPEUTICS Corp files a new trade →